Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bayer Ag Ord (OP: BAYZF )

30.89 -0.05 (-0.15%)
Streaming Delayed Price Updated: 11:16 AM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,668
Open 30.70
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 30.94
Today's Range 30.70 - 30.89
52wk Range 26.91 - 57.58
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Futures Rally Fizzles As Dollar, Yields And Oil Slump
US equity futures erased earlier gains and were trading with modest losses as the dollar, oil, and yields all slumped entering the US session. 
Via Talk Markets
Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer
Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company's stance that product is safe. 
Via Benzinga
Topics Lawsuit
Exposures Financial Glyphosate Legal

Performance

YTD
-18.19%
-18.19%
1 Month
+4.26%
+4.26%
3 Month
-0.28%
-0.28%
6 Month
+1.29%
+1.29%
1 Year
-42.82%
-42.82%

More News

Read More
Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M
Via Benzinga
Exposures Glyphosate
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Via Benzinga
Topics Data Breach
Exposures Information Security
Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval
Via Benzinga
Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned
Via Benzinga
Exposures Glyphosate
Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant
Via Benzinga
Exposures Product Safety
German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits
Via Benzinga
Topics Bankruptcy Lawsuit
Exposures Financial Glyphosate Legal
Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges
Via Benzinga
What's Going On With BridgeBio Pharma Stock On Monday?
Via Benzinga
Exposures Product Safety
Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial
Via Benzinga
Topics Lawsuit
Exposures Financial Glyphosate Legal
Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout
Via Benzinga
Exposures Glyphosate
Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance
Via Benzinga
Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial
Via Benzinga
Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial
Via Benzinga
Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak
Via Benzinga
Topics Lawsuit
Exposures Financial Glyphosate Legal
ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US
Via Benzinga
Topics Climate Change
Exposures Climate
Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss
Via Benzinga
Exposures Glyphosate
Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion
Via Benzinga
Topics Lawsuit
Exposures Financial Glyphosate Legal
German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks
Via Benzinga
Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence
Via Benzinga
Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details
Via Benzinga
Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss
Via Benzinga
Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss
Via Benzinga
Exposures Glyphosate
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.